Literature DB >> 23839706

Contrast-induced nephropathy in patients with aneurysmal subarachnoid hemorrhage.

Vamsidhar Chavakula1, Bradley A Gross, Kai U Frerichs, Rose Du.   

Abstract

INTRODUCTION: Patients with aneurysmal subarachnoid hemorrhage (SAH) frequently undergo multiple angiographic studies within a 48-h period. We sought to evaluate the impact of these repeated contrast loads on renal function.
METHODS: We reviewed the records of a consecutive series of 104 patients with aneurysmal subarachnoid hemorrhage, most of whom underwent at least an initial CT angiogram and digital subtraction angiography. Six patients had baseline renal disease. Initial creatinine levels were compared to maximum levels over a subsequent 48-h period after their last angiographic study. We defined contrast-induced nephropathy (CIN) as an increase in creatinine of at least 0.3 from baseline.
RESULTS: The mean change in creatinine following treatment was 0.05 ± 0.23, with three patients developing CIN (2.9%). In 2 cases of CIN, the creatinine increase was inconsequential (0.39 and 0.44). All patients with CIN had an early return of their creatinine to baseline; none required dialysis or suffered permanent sequelae as a result of these creatinine increases. There was no statistically significant difference in the rate of CIN in patients treated with microsurgical clipping (n = 85) as compared to those who underwent coiling (n = 19).
CONCLUSION: Our results underscore the relative safety of the usage of multiple angiographic studies performed in patients with aneurysmal SAH, particularly in patients without baseline renal disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23839706     DOI: 10.1007/s12028-013-9843-0

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  12 in total

1.  Determinants of central sympathetic activation in spontaneous primary subarachnoid hemorrhage.

Authors:  Michael Moussouttas; Edwin W Lai; John Khoury; Thanh T Huynh; Keith Dombrowski; Karel Pacak
Journal:  Neurocrit Care       Date:  2012-06       Impact factor: 3.210

2.  Hospital mortality and complications of electively clipped or coiled unruptured intracranial aneurysm.

Authors:  Amer Alshekhlee; Sonal Mehta; Randall C Edgell; Nirav Vora; Eli Feen; Afshin Mohammadi; Sushant P Kale; Salvador Cruz-Flores
Journal:  Stroke       Date:  2010-06-03       Impact factor: 7.914

Review 3.  Prophylaxis strategies for contrast-induced nephropathy.

Authors:  Neesh Pannu; Natasha Wiebe; Marcello Tonelli
Journal:  JAMA       Date:  2006-06-21       Impact factor: 56.272

Review 4.  Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR).

Authors:  S K Morcos; H S Thomsen; J A Webb
Journal:  Eur Radiol       Date:  1999       Impact factor: 5.315

Review 5.  Intracranial aneurysms in patients with subarachnoid hemorrhage: CT angiography as a primary examination tool for diagnosis--systematic review and meta-analysis.

Authors:  Henriëtte E Westerlaan; J M C van Dijk; M J van Dijk; Marijke C Jansen-van der Weide; Jan Cees de Groot; Rob J M Groen; Jan Jakob A Mooij; Matthijs Oudkerk
Journal:  Radiology       Date:  2010-10-08       Impact factor: 11.105

6.  Detection of circle of Willis aneurysms in patients with acute subarachnoid hemorrhage: a comparison of CT angiography and digital subtraction angiography.

Authors:  P T Vieco; W P Shuman; G F Alsofrom; C E Gross
Journal:  AJR Am J Roentgenol       Date:  1995-08       Impact factor: 3.959

7.  The value of computed tomography angiography in determining treatment allocation for aneurysmal subarachnoid hemorrhage.

Authors:  Jefferson T Miley; Robert A Taylor; Vallabh Janardhan; Ramachandra Tummala; Giuseppe Lanzino; Adnan I Qureshi
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

8.  Results of a prospective protocol of computed tomographic angiography in place of catheter angiography as the only diagnostic and pretreatment planning study for cerebral aneurysms by a combined neurovascular team.

Authors:  Brian L Hoh; Arnold C Cheung; James D Rabinov; Johnny C Pryor; Bob S Carter; Christopher S Ogilvy
Journal:  Neurosurgery       Date:  2004-06       Impact factor: 4.654

9.  Renal safety of CT angiography and perfusion imaging in the emergency evaluation of acute stroke.

Authors:  J J Hopyan; D J Gladstone; G Mallia; J Schiff; A J Fox; S P Symons; B H Buck; S E Black; R I Aviv
Journal:  AJNR Am J Neuroradiol       Date:  2008-08-21       Impact factor: 3.825

10.  CT angiography for intracerebral hemorrhage does not increase risk of acute nephropathy.

Authors:  Alexandra Oleinik; Javier M Romero; Kristin Schwab; Michael H Lev; Nupur Jhawar; Josser E Delgado Almandoz; Eric E Smith; Steven M Greenberg; Jonathan Rosand; Joshua N Goldstein
Journal:  Stroke       Date:  2009-05-21       Impact factor: 7.914

View more
  4 in total

1.  Effect of Hydroxyethyl Starch Solution on Incidence of Acute Kidney Injury in Patients Suffering from Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage.

Authors:  Martin Kieninger; Daniel Unbekannt; André Schneiker; Barbara Sinner; Sylvia Bele; Christopher Prasser
Journal:  Neurocrit Care       Date:  2017-02       Impact factor: 3.210

2.  Hypernatremia is a significant risk factor for acute kidney injury after subarachnoid hemorrhage: a retrospective analysis.

Authors:  Avinash B Kumar; Yaping Shi; Matthew S Shotwell; Justin Richards; Jesse M Ehrenfeld
Journal:  Neurocrit Care       Date:  2015-04       Impact factor: 3.210

3.  High-sensitivity C-reactive protein as a predictive factor of acute kidney injury following aneurysmal subarachnoid hemorrhage: a prospective observational study.

Authors:  Bi-Hui Yang; Qiu He; Chen-Yu Ding; De-Zhi Kang; Qing-Xi Tang
Journal:  Acta Neurochir (Wien)       Date:  2019-07-17       Impact factor: 2.216

4.  Contrast-Induced Acute Kidney Injury after Coil Embolization for Aneurysmal Subarachnoid Hemorrhage.

Authors:  Hyun Goo Lee; Won Ki Kim; Je Young Yeon; Jong Soo Kim; Keon Ha Kim; Pyoung Jeon; Seung Chyul Hong
Journal:  Yonsei Med J       Date:  2018-01       Impact factor: 2.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.